Theravance Biopharma Inc banner

Wall St Price Targets

TBPH Price Forecast
No price targets yet

We don't have analyst price targets for TBPH yet.

TBPH Analyst Rating
Based on 4 analysts

avg. 3.75 of 5
Strong buy
1 25%
Buy
1 25%
Hold
2 50%
Sell
0 0%
Strong sell
0 0%

Analysts rate TBPH Buy, with 2 of 4 recommending Buy or Strong buy.

Theravance Biopharma Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TBPH's stock price target?
Not Available

TBPH does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Theravance Biopharma Inc?
Projected CAGR
0%

Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 8 years is 0%.

What is the Pre-Tax Income forecast for Theravance Biopharma Inc?
Projected CAGR
-24%

The compound annual growth rate for Pre-Tax Income over the next 3 years is -24%.

What is the Net Income forecast for Theravance Biopharma Inc?
Projected CAGR
1%

The compound annual growth rate for Net Income over the next 6 years is 1%.

Back to Top